Avner Schlessinger

9.9k total citations · 3 hit papers
110 papers, 6.0k citations indexed

About

Avner Schlessinger is a scholar working on Molecular Biology, Biochemistry and Oncology. According to data from OpenAlex, Avner Schlessinger has authored 110 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Molecular Biology, 32 papers in Biochemistry and 27 papers in Oncology. Recurrent topics in Avner Schlessinger's work include Amino Acid Enzymes and Metabolism (32 papers), Drug Transport and Resistance Mechanisms (23 papers) and Protein Structure and Dynamics (19 papers). Avner Schlessinger is often cited by papers focused on Amino Acid Enzymes and Metabolism (32 papers), Drug Transport and Resistance Mechanisms (23 papers) and Protein Structure and Dynamics (19 papers). Avner Schlessinger collaborates with scholars based in United States, United Kingdom and France. Avner Schlessinger's co-authors include Burkhard Rost, Andrej Săli, Peter M.U. Ung, Claire Colas, Kathleen M. Giacomini, Marco Punta, Guy Yachdav, Hao Fan, John J. Irwin and Thomas E. Ferrin and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Avner Schlessinger

104 papers receiving 5.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ModBase, a database of annotated comparative protein structure models, and associated resources

2010 672 citations Ursula Pieper, Avner Schlessinger et al. profile →
PredictProtein—an open resource for online prediction of protein structural and functional features

2014 455 citations Avner Schlessinger, Burkhard Rost et al. profile →
Artificial intelligence and machine learning‐aided drug discovery in central nervous system diseases: State‐of‐the‐arts and future directions

2020 252 citations Avner Schlessinger et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Avner Schlessinger	4.2k	874	759	658	551	110	6.0k
Douglas S. Auld	4.8k 1.1×	663 0.8×	449 0.6×	328 0.5×	365 0.7×	120	7.1k
Stephen C. Meredith	4.8k 1.1×	943 1.1×	203 0.3×	546 0.8×	421 0.8×	110	8.5k
Simon Newstead	3.6k 0.8×	871 1.0×	494 0.7×	446 0.7×	632 1.1×	84	5.3k
Jianping Ding	7.8k 1.9×	612 0.7×	269 0.4×	549 0.8×	921 1.7×	187	11.8k
Elizabeth J. Goldsmith	9.8k 2.3×	1.2k 1.4×	499 0.7×	926 1.4×	668 1.2×	108	12.7k
Paola Picotti	7.3k 1.7×	791 0.9×	192 0.3×	429 0.7×	574 1.0×	110	10.5k
Masoud Vedadi	7.9k 1.9×	968 1.1×	165 0.2×	650 1.0×	598 1.1×	141	9.7k
Chuangye Yan	8.0k 1.9×	659 0.8×	404 0.5×	623 0.9×	536 1.0×	105	10.8k
Lucy R. Forrest	3.8k 0.9×	522 0.6×	531 0.7×	412 0.6×	463 0.8×	95	5.0k
Milton T. Stubbs	3.4k 0.8×	607 0.7×	123 0.2×	511 0.8×	468 0.8×	117	5.6k

Countries citing papers authored by Avner Schlessinger

Since Specialization

Citations

This map shows the geographic impact of Avner Schlessinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avner Schlessinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avner Schlessinger more than expected).

Fields of papers citing papers by Avner Schlessinger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avner Schlessinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avner Schlessinger. The network helps show where Avner Schlessinger may publish in the future.

Co-authorship network of co-authors of Avner Schlessinger

This figure shows the co-authorship network connecting the top 25 collaborators of Avner Schlessinger. A scholar is included among the top collaborators of Avner Schlessinger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avner Schlessinger. Avner Schlessinger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Duffy, Áine, David Stein, Joshua K. Park, et al.. (2025). Development of a genetic priority score to predict drug side effects using human genetic evidence. Nature Communications. 16(1). 8713–8713.

Zhao, Yulin, et al.. (2025). A critical residue mediates proper assembly and gating of GIRK2 channels. The Journal of General Physiology. 158(1).

Stein, David, Matthew Mort, Peter D. Stenson, et al.. (2025). Expanding the utility of variant effect predictions with phenotype-specific models. Nature Communications. 16(1). 11113–11113.

Yu, Gongqi, Abigail L. Thorpe, Marjan Ilkov, et al.. (2025). BPS2025 - Comprehensive analysis of human solute carrier superfamily in Alzheimer's disease using multimodal sequencing data. Biophysical Journal. 124(3). 290a–290a.

Duffy, Áine, Ben Omega Petrazzini, David Stein, et al.. (2024). Development of a human genetics-guided priority score for 19,365 genes and 399 drug indications. Nature Genetics. 56(1). 51–59. 11 indexed citations

Li, Yan Chak, et al.. (2024). A comprehensive exploration of the druggable conformational space of protein kinases using AI-predicted structures. PLoS Computational Biology. 20(7). e1012302–e1012302. 7 indexed citations

Sekar, John A. P., Yan Chak Li, Avner Schlessinger, & Gaurav Pandey. (2024). A web portal for exploring kinase-substrate interactions. npj Systems Biology and Applications. 10(1). 113–113. 1 indexed citations

Duffy, Áine, Ben Omega Petrazzini, Ha My T. Vy, et al.. (2024). Expanding drug targets for 112 chronic diseases using a machine learning-assisted genetic priority score. Nature Communications. 15(1). 8891–8891. 5 indexed citations

Yang, Dong, et al.. (2023). Conserved allosteric inhibition mechanism in SLC1 transporters. eLife. 12. 12 indexed citations

10.

McInnes, Gregory, Julia E. H. Brown, Neil Thomas, et al.. (2022). Functional genomics of OCTN2 variants informs protein-specific variant effect predictor for Carnitine Transporter Deficiency. Proceedings of the National Academy of Sciences. 119(46). e2210247119–e2210247119. 12 indexed citations

11.

Adamopoulos, Christos, Tamer A. Ahmed, Maxwell R. Tucker, et al.. (2021). Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. Cancer Discovery. 11(7). 1716–1735. 40 indexed citations

12.

Rahman, Rayees, Jens Hansen, Yuguang Xiong, et al.. (2021). Protein structure–based gene expression signatures. Proceedings of the National Academy of Sciences. 118(19). 5 indexed citations

13.

Garaeva, Alisa A., Massimiliano Bonomi, Dirk Jan Slotboom, et al.. (2021). Rational design of ASCT2 inhibitors using an integrated experimental-computational approach. Proceedings of the National Academy of Sciences. 118(37). 47 indexed citations

14.

Lizarraga, Sofia B., Li Ma, Laura I. van Dyck, et al.. (2021). Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies. Science Translational Medicine. 13(580). 20 indexed citations

15.

Hasselt, J. G. Coen van, Rayees Rahman, Jens Hansen, et al.. (2020). Transcriptomic profiling of human cardiac cells predicts protein kinase inhibitor-associated cardiotoxicity. Nature Communications. 11(1). 4809–4809. 28 indexed citations

16.

Dewulf, Joseph P., Elsa Wiame, Imen Dorboz, et al.. (2019). SLC13A3 variants cause acute reversible leukoencephalopathy and α‐ketoglutarate accumulation. Annals of Neurology. 85(3). 385–395. 19 indexed citations

17.

Feiglin, Ariel, et al.. (2014). Co-expression and co-localization of hub proteins and their partners are encoded in protein sequence. Molecular BioSystems. 10(4). 787–794. 1 indexed citations

18.

Schlessinger, Avner, Ethan G. Geier, Hao Fan, et al.. (2011). Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET. Proceedings of the National Academy of Sciences. 108(38). 15810–15815. 104 indexed citations

19.

Gruswitz, Franz, Sarika Chaudhary, Joseph D. Ho, et al.. (2010). Function of human Rh based on structure of RhCG at 2.1 Å. Proceedings of the National Academy of Sciences. 107(21). 9638–9643. 163 indexed citations

20.

Schlessinger, Avner, Pär Matsson, James E. Shima, et al.. (2010). Comparison of human solute carriers. Protein Science. 19(3). 412–428. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact